Goldman Sachs MARUWA (5344.T): Results Briefing — AI Sales Growth to Accelerate in 2H on New Plant Launch; Expanding CPO Contribution; Buy
Summaries are public. PDF access requires an active membership; all members have the same access. Sign in
Goldman Sachs maintains its Buy rating on MARUWA (5344.T), emphasizing that the company is positioned for a significant acceleration in AI-related sales growth starting in the second half of 2026. The primary catalysts driving this expected growth trajectory are the timely launch of a new manufacturing plant and the expanding revenue contribution from co-packaged optics (CPO) technology.
Based on the recent results briefing, the firm highlights a constructive outlook for the company's AI business pipeline. Management's commentary suggests that the commercialization progress of CPO technology is aligning with expectations, creating a new growth engine alongside the company's traditional operations.
Goldman Sachs believes the current valuation remains highly attractive. At present levels, the stock trades at approximately 25 times forward earnings estimates for fiscal year 2027. The investment bank argues that the broader market has not yet fully priced in the upcoming growth potential associated with these strategic initiatives. Consequently, the combination of an upcoming capacity ramp and technological diversification supports a favorable risk-reward profile. The report notes that no specific target price was issued in this update, but the fundamental thesis remains intact based on anticipated second-half momentum and operational leverage.